Q: What is Atezolizumab used for?

Atezolizumab is used to treat: urothelial carcinoma non-small cell lung cancer small cell lung cancer and others

Q: How does Atezolizumab work?

How Atezolizumab Works Atezolizumab is a type of medication called a monoclonal antibody. It is designed to target a specific protein known as programmed death-ligand 1 (PD-L1), which is found on the surface of some cancer cells and certain immune cells. In a healthy body, the PD-L1 protein helps keep the immune system from attacking normal cells. However, some cancer cells use this protein to avoid being detected. When PD-L1 binds to receptors on T-cells (a type of white blood cell that fights disease), it sends a signal that tells the T-cells to stay inactive. This prevents the immune system from attacking the cancer. Atezolizumab works by attaching to the PD-L1 protein and blocking it from connecting with the receptors on T-cells. By interfering with this process, the medication: Restores the immune response by allowing T-cells to recognize cancer cells as a threat. Enables the immune system to find and attack the tumor cells. Slows or stops the growth and spread of the cancer. Because this treatment uses the body's own immune system to fight the disease, it is classified as a type of immunotherapy.

Q: What are the brand names for Atezolizumab?

Atezolizumab is sold under the brand name Tecentriq .

Q: What are the active ingredients in Atezolizumab?

The active ingredient in Atezolizumab is atezolizumab .

Q: What are the side effects of Atezolizumab?

Common side effects of Atezolizumab may include: Fatigue Decreased appetite Nausea and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Atezolizumab?

Atezolizumab belongs to the PD-L1 inhibitor drug class.

Q: What is the dosage of Atezolizumab and how do I take it?

Administration Methods Atezolizumab is administered by a healthcare professional in a medical facility, such as a hospital or clinic. It is available in two different forms: an intravenous (IV) infusion and a subcutaneous injection. Intravenous Infusion When given as an infusion, the medication is delivered into a vein through a needle or catheter. The timing of these infusions generally follows these patterns: The first treatment is usually administered slowly so that healthcare providers can monitor for any infusion-related reactions. If the first dose is well-tolerated, subsequent infusions may be administered over a shorter period of time. Infusions are typically scheduled at regular intervals, such as every two, three, or four weeks. Subcutaneous Injection The subcutaneous form of this medication is injected under the skin, typically in the thigh area. This administration method generally takes several minutes to complete. Missed Doses If you miss an appointment for a dose of atezolizumab, contact your healthcare provider as soon as possible to reschedule. It is important to receive each dose as planned to maintain the effectiveness of the treatment. Do not wait until the next scheduled appointment to report a missed dose. Treatment Considerations Your healthcare provider will determine the appropriate schedule and duration of treatment based on your specific condition, how well the medication is working, and whether you experience any significant side effects. You may receive this medication alone or in combination with other chemotherapy drugs.

Q: Is Atezolizumab safe during pregnancy and breastfeeding?

Pregnancy Based on its mechanism of action and animal studies, atezolizumab can cause fetal harm when administered to a pregnant woman. It may increase the risk of pregnancy loss or cause birth defects. Healthcare providers typically advise against starting this treatment if you are pregnant unless the potential benefit justifies the potential risk to the fetus. Females who are able to become pregnant should have a pregnancy test before starting treatment. It is recommended to use effective birth control during treatment and for at least 5 months after the final dose of atezolizumab. Breastfeeding There is no information available regarding the presence of atezolizumab in human breast milk, its effects on the breastfed child, or its effects on milk production. Because of the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for at least 5 months after the last dose.

Question 1

What is Atezolizumab?

Accepted Answer

Atezolizumab is a type of medication known as a programmed death-ligand 1 (PD-L1) blocking antibody. It belongs to a class of drugs called monoclonal antibodies, which are laboratory-made proteins designed to target specific structures in the body.

This therapy works by binding to the PD-L1 protein found on certain cells. By blocking the interaction of this protein, the medication helps the immune system recognize and attack cancer cells.

Question 2

What is Atezolizumab used for?

Accepted Answer

Atezolizumab is used to treat:

urothelial carcinoma
non-small cell lung cancer
small cell lung cancer
and others

Question 3

How does Atezolizumab work?

Accepted Answer

How Atezolizumab Works

Atezolizumab is a type of medication called a monoclonal antibody. It is designed to target a specific protein known as programmed death-ligand 1 (PD-L1), which is found on the surface of some cancer cells and certain immune cells.

In a healthy body, the PD-L1 protein helps keep the immune system from attacking normal cells. However, some cancer cells use this protein to avoid being detected. When PD-L1 binds to receptors on T-cells (a type of white blood cell that fights disease), it sends a signal that tells the T-cells to stay inactive. This prevents the immune system from attacking the cancer.

Atezolizumab works by attaching to the PD-L1 protein and blocking it from connecting with the receptors on T-cells. By interfering with this process, the medication:

Restores the immune response by allowing T-cells to recognize cancer cells as a threat.
Enables the immune system to find and attack the tumor cells.
Slows or stops the growth and spread of the cancer.

Because this treatment uses the body's own immune system to fight the disease, it is classified as a type of immunotherapy.

Question 4

What are the brand names for Atezolizumab?

Accepted Answer

Atezolizumab is sold under the brand name Tecentriq.

Question 5

What are the active ingredients in Atezolizumab?

Accepted Answer

The active ingredient in Atezolizumab is atezolizumab.

Question 6

What are the side effects of Atezolizumab?

Accepted Answer

Common side effects of Atezolizumab may include:

Fatigue
Decreased appetite
Nausea
and others.

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Atezolizumab?

Accepted Answer

Atezolizumab belongs to the PD-L1 inhibitor drug class.

Question 8

What is the dosage of Atezolizumab and how do I take it?

Accepted Answer

Administration Methods

Atezolizumab is administered by a healthcare professional in a medical facility, such as a hospital or clinic. It is available in two different forms: an intravenous (IV) infusion and a subcutaneous injection.

Intravenous Infusion

When given as an infusion, the medication is delivered into a vein through a needle or catheter. The timing of these infusions generally follows these patterns:

The first treatment is usually administered slowly so that healthcare providers can monitor for any infusion-related reactions.
If the first dose is well-tolerated, subsequent infusions may be administered over a shorter period of time.
Infusions are typically scheduled at regular intervals, such as every two, three, or four weeks.

Subcutaneous Injection

The subcutaneous form of this medication is injected under the skin, typically in the thigh area. This administration method generally takes several minutes to complete.

Missed Doses

If you miss an appointment for a dose of atezolizumab, contact your healthcare provider as soon as possible to reschedule. It is important to receive each dose as planned to maintain the effectiveness of the treatment. Do not wait until the next scheduled appointment to report a missed dose.

Treatment Considerations

Your healthcare provider will determine the appropriate schedule and duration of treatment based on your specific condition, how well the medication is working, and whether you experience any significant side effects. You may receive this medication alone or in combination with other chemotherapy drugs.

Question 9

Is Atezolizumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Based on its mechanism of action and animal studies, atezolizumab can cause fetal harm when administered to a pregnant woman. It may increase the risk of pregnancy loss or cause birth defects. Healthcare providers typically advise against starting this treatment if you are pregnant unless the potential benefit justifies the potential risk to the fetus.

Females who are able to become pregnant should have a pregnancy test before starting treatment. It is recommended to use effective birth control during treatment and for at least 5 months after the final dose of atezolizumab.

Breastfeeding

There is no information available regarding the presence of atezolizumab in human breast milk, its effects on the breastfed child, or its effects on milk production. Because of the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for at least 5 months after the last dose.

Question 10

What forms and strengths does Atezolizumab come in?

Accepted Answer

Atezolizumab is provided in the following administration formats:

Intravenous Infusion: This form is a concentrated, preservative-free solution supplied in single-dose vials. It must be diluted by a healthcare provider before being administered into a vein.
Subcutaneous Injection: This form is a solution for injection under the skin, typically in the thigh. This version is a combination product that includes an enzyme to assist the body in absorbing the medication.

Question 11

What is the FDA approval status of Atezolizumab?

Accepted Answer

FDA Approval and Indications

Atezolizumab is approved by the U.S. Food and Drug Administration (FDA) for the treatment of several types of cancer. It is used in adults and, in some cases, pediatric patients for conditions including:

Non-small cell lung cancer
Small cell lung cancer
Hepatocellular carcinoma (a type of liver cancer)
Melanoma
Alveolar soft part sarcoma

The FDA has approved two methods of administration: an intravenous infusion and a subcutaneous injection. The subcutaneous version, which includes the enzyme hyaluronidase to aid absorption, was approved in 2024 for use in all adult indications previously established for the intravenous form.

Regulatory Status

Atezolizumab is available only by prescription. It belongs to a class of drugs known as PD-L1 blocking antibodies. While it carries significant warnings regarding immune-mediated side effects, it does not currently have a Boxed Warning or a Risk Evaluation and Mitigation Strategy (REMS) program required by the FDA.

Question 12

What should I know about Atezolizumab and cost?

Accepted Answer

Factors Affecting Price

Atezolizumab is a specialized biologic medication administered by healthcare professionals. The total cost of therapy is influenced by:

Administration Method: Costs may vary depending on whether the drug is given as an intravenous (IV) infusion or a subcutaneous injection.
Treatment Setting: The price can differ based on whether the medication is received in a hospital, a specialized infusion center, or a doctor's office.
Dosage and Frequency: The amount of medication required and how often it is administered (such as every two, three, or four weeks) will impact the overall expense.

Insurance and Financial Support

Most insurance plans, including Medicare and private insurers, typically cover atezolizumab when it is used for approved medical conditions. However, patients may still be responsible for out-of-pocket expenses like deductibles or coinsurance. Because it is a high-cost specialty drug, some patients may be eligible for financial assistance programs or co-pay support offered by the manufacturer.

Biosimilar Status

Currently, there are no FDA-approved biosimilar versions of atezolizumab. It is only available as a brand-name product, which generally means the cost remains higher than it would be if generic or biosimilar alternatives were available on the market.

Atezolizumab

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Atezolizumab

Hospitals.net Disclosure